Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatneik J, Miller SM. Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers Dement. 2011;7:532–9. https://doi.org/10.1016/J.JALZ.2011.05.2410

Article  PubMed  Google Scholar 

Atri A. The Alzheimer’s disease clinical spectrum: diagnosis and management. Med Clin North Am. 2019;103:263–93. https://doi.org/10.1016/J.MCNA.2018.10.009

Article  PubMed  Google Scholar 

Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prev Alzheimers Dis. 2021;8:371–86. https://doi.org/10.14283/JPAD.2021.23

Article  CAS  PubMed  Google Scholar 

Knopman DS, Amieva H, Petersen RC, Chetelat G, Holtzman DM, Hyman BT, Jones DT. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33. https://doi.org/10.1038/S41572-021-00269-Y

Article  PubMed  PubMed Central  Google Scholar 

Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8:595–608. https://doi.org/10.15252/EMMM.201606210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar A, Singh A, Ekavali. A review on Alzheimer’s disease pathophysiology and its management: An update. Pharmacol. Rep. 2015;67:195–203. https://doi.org/10.1016/j.pharep.2014.09.004

Article  CAS  PubMed  Google Scholar 

Deture MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14:32. https://doi.org/10.1186/S13024-019-0333-5

Article  PubMed  PubMed Central  Google Scholar 

Kametani F, Hasegawa M. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer’s disease. Front Neurosci. 2018;12:25. https://doi.org/10.3389/FNINS.2018.00025

Article  PubMed  PubMed Central  Google Scholar 

Aisen PS, Cummings J, Jack CR, Morris JC, Sperling R, Frolich L, Dubois B. On the path to 2025: understanding the Alzheimer’s disease continuum. Alzheimers Res Ther. 2017;9:60. https://doi.org/10.1186/S13195-017-0283-5

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Ma Q, Zhang YW, Xu H. Proteolytic processing of Alzheimer’s β-amyloid precursor protein. J Neurochem. 2012;120:9–21. https://doi.org/10.1111/J.1471-4159.2011.07519.X

Article  CAS  PubMed  Google Scholar 

Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonesca J, Taghva K Alzheimer’s disease drug development pipeline: 2022. Alzheimers Dement. 2022;8:e12295. https://doi.org/10.1002/TRC2.12295

Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. 2020. Alzheimer’s disease drug development pipeline: 2020. Alzheimers and Dement. 2020;6:e12050. https://doi.org/10.1002/trc2.12050

Article  Google Scholar 

Sevigny J, Chiao P, Bussière T. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. 2016;537:50–56. https://doi.org/10.1038/nature19323

Article  CAS  PubMed  Google Scholar 

Salloway S, Chalkias S, Barkhof F, Barakos J, Purcell D, Suhy J, Smirnakis K. Amyloid-related imaging abnormalities in 2 Phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2022;79:13–21. https://doi.org/10.1001/JAMANEUROL.2021.4161

Article  PubMed  Google Scholar 

Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Iwatsubo T. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388:142–3. https://doi.org/10.1056/NEJMOA2212948

Article  Google Scholar 

Reardon S. Alzheimer’s drug donanemab: what promising trial means for treatments. Nature. 2023;617:232–3. https://doi.org/10.1038/D41586-023-01537-5

Article  CAS  PubMed  Google Scholar 

Makurvet FD. Biologics vs. small molecules: Drug costs and patient access. Med Drug Discov. 2021;9:100075. https://doi.org/10.1016/J.MEDIDD.2020.100075

Article  Google Scholar 

Mohamed T, Yeung JCK, Vasefi MS, Beazely MA, Rao PPN. Development and evaluation of multifunctional agents for potential treatment of Alzheimer’s disease: Application to a pyrimidine-2,4-diamine template. Bioorg Med Chem Lett. 2012;22:4707–12. https://doi.org/10.1016/j.bmcl.2012.05.077

Article  CAS  PubMed  Google Scholar 

Mohamed T, Shakeri A, Tin G, Rao PPN. Structure-activity relationship studies of isomeric 2,4-diaminoquinazolines on β-amyloid aggregation kinetics. ACS Med Chem Lett. 2016;7:502–7. https://doi.org/10.1021/acsmedchemlett.6b00039

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohamed T, Shakeri A, Rao PPN. Amyloid cascade in Alzheimer’s disease: recent advances in medicinal chemistry. Eur J Med Chem. 2016;113:258–72. https://doi.org/10.1016/J.EJMECH.2016.02.049

Article  CAS  PubMed  Google Scholar 

Sashidhara KV, Kumar M, Modukuri RK, Sonkar R, Bhatia G, Khanna AK, Shukla R. Synthesis and anti-inflammatory activity of novel biscoumarin–chalcone hybrids. Bioorg Med Chem Lett. 2011;21:4480–4. https://doi.org/10.1016/j.bmcl.2011.06.002

Article  CAS  PubMed  Google Scholar 

Kim MJ, Lee YH, Kwak J, Na Y, Yoon HG. Protective effects of a chalcone derivative against Aβ-induced oxidative stress and neuronal damage. BMB Rep. 2011;44:730–4. https://doi.org/10.5483/BMBREP.2011.44.11.730

Article  CAS  PubMed  Google Scholar 

Cao Z, Yang J, Xu R, Song Q, Zhang X, Liu H, Deng Y. Design, synthesis and evaluation of 4’-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer’s disease treatment. Bioorg Med Chem. 2018;26:1102–15. https://doi.org/10.1016/J.BMC.2018.01.030

Article  CAS  PubMed  Google Scholar 

Liu HR, Liu XJ, Fan HQ, Tang JJ, Gao XH, Liu WK. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem. 2014;22:6124–33. https://doi.org/10.1016/J.BMC.2014.08.033

Article  CAS  PubMed  Google Scholar 

Jackson PA, Widen JC, Harki DA, Brummond KM. Covalent modifiers: a chemical perspective on the reactivity of α,β-unsaturated carbonyls with thiols via hetero-Michael addition reactions. J Med Chem. 2017;60:839–85. https://doi.org/10.1021/ACS.JMEDCHEM.6B00788

Article  CAS  PubMed  Google Scholar 

Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z. Chalcone: a privileged structure in medicinal chemistry. Chem Rev. 2017;117:762–7810. https://doi.org/10.1021/acs.chemrev.7b00020

Article  CAS  Google Scholar 

Baell J, Walters MA. Chemistry: chemical con artists foil drug discovery. Nature. 2014;513:481–3. https://doi.org/10.1038/513481A

Article  CAS  PubMed  Google Scholar 

Baell JB. Redox-active nuisance screening compounds and their classification. Drug Discov Today. 2011;16:840–1. https://doi.org/10.1016/j.drudis.2011.06.011

Article  CAS  Google Scholar 

Burgos-Morón E, Calderón-Montaño JM, Salvador J, Robles A, Lazaro ML. The dark side of curcumin. Int J Cancer. 2010;126:1771–5. https://doi.org/10.1002/IJC.24967

Article  PubMed  Google Scholar 

Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010;53:2719–40. https://doi.org/10.1021/JM901137J

Article  CAS  PubMed